Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry Through Consistent Quality Assurance, On-time Delivery, Sustainability, and Competitive Costs
Bushu Pharma's ongoing investments and efforts offer customers state-of-the-art capabilities, increased capacity,…
The Esthetic Clinics Attracts 15% Global Patients to India, Amid Cosmetic Surgery Medical Tourism Boom: MedTalks News
MUMBAI, India, Dec. 13, 2024 /PRNewswire/ -- MedTalks News features The Esthetic Clinics®…
Star Health Introduces ‘SUPER STAR’- A Long-Term Retail Offering
Offers a long-term policy and unparalleled, highly customisable solutions for evolving healthcare…
Axtria Leads Frost & Sullivan’s First Pharmaceutical Commercialization Solutions and Services Industry Radar Report
BERKELEY HEIGHTS, N.J., Dec. 12, 2024 /PRNewswire/ -- Axtria Inc., a global…
Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
Kellner Group Denounces False Rumors About AIM Short Selling and Demands Immediate Accountability from Incumbent Board
December 14, 2024 16:54 ET | Source: Kellner Group Vote “FOR” All…
Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close
Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions…
Rakovina Therapeutics Announces Closing of Oversubscribed $3M Private Placement
December 13, 2024 18:50 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…
Checkpoint Therapeutics Announces FDA Approval of UNLOXCYT(cosibelimab-ipdl)
WALTHAM, Mass., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”)…
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares
December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The…
